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A recent report from our laboratory showed that in the serum of many 
Reye’s syndrome (RS) patients, ornithine carbamyl transferase (OCT, 
Carbamyl phosphate: L-ornithine carbamyl transferase; EC 2.1.3.3.) ac- 
tivities were elevated during acute illness (1). In the present paper, serum 
OCT activities of acutely ill RS patients are compared with those of 
convalescent RS patients, their parents, and non-RS childhood control 
subjects, and the significance of serum OCT elevation in RS is discussed. 
METHODS 
The 47 serum samples of RS patients, taken during the acute illness 
were the residua of samples collected during the period 1974-1982 for 
diagnostic and related clinical examination. Thirty-seven of those samples 
were collected between 1974-1981, and serum OCT activities in those 
samples have been reported previously (1). The recovered RS patients 
were selected from cases reported to the Michigan Department of Public 
Health between January 1, 1980 and December 31, 1982. Only cases who 
were 5 years old or greater at the time of diagnosis and locatable residents 
of Michigan and who met the Centers for Disease Control (CDC) cases 
definition of stage II or greater RS were chosen (2). Serum specimens 
were also collected from the locatable biologic parents of the RS cases 
who were living in Michigan at the time of study. Of 42 eligible families, 
41 agreed to partake in the study. The control specimens were taken 
from 47 school-age children from Jackson County, Michigan, who (with 
the approval of their parents) consented to provide blood samples for 
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RS-related research. according to a protocol approved by the University 
of Michigan, institutional Committee. 
Blood specimens from the recovered RS patients and their parents 
were collected in acid citrate dextrose and centrifuged at 5000~ for IS 
min. Plasma was separated and stored at -20°C. Serum OCT activity 
was determined by the method of Cerriotti (3) and expressed as units/ 
liter. Student’s t test was used to calculate the statistical significance. /-’ 
values co.05 were considered significant. 
RESULTS 
Serum OCT values of IO stage 1 and 37 stage II-IV RS patients are 
shown in Table I. Serum OCT values for 7 of those stage I and 30 of 
stage II-IV RS patients were reported previously (I). The remaining 
three stage 1 patients and seven stage II-IV patients had serum OCT 
activities of 81.7 +- 14.1 and 18.1 t 3.1, respectively (means t SEM). 
Serum OCT levels of acutely ill and convalescent RS patients are also 
shown in Table I. The mean level in the convalescent RS patients and 
their parents were within normal range (O-10 units/liter) and were not 
significantly different from the controls. 
DISCUSSION 
Several reports indicate that the liver mitochondrial abnormalities, 
which are consistently seen in RS patients may be partially responsible 
for the metabolic disorders observed in this syndrome (4,5). Decreased 
liver OCT activities have been reported in RS patients during the early 
phase of disorder (6). Our study suggests that the decrease in liver OCT 
activity was associated with an increase in serum OCT activity. because 
all the stage I patients had high serum OCT activities compared to stage 
II-IV patients and also compared to controls. The finding of normal 
TABLE I 
SERUM ORNITHINE CARBAMYL TKANSFERASE ACTIWIES IN REYE’S SYNDROME PATIENTS 
AND THEIR PARENTS 
Parents of 
Reye’s syndrome 
Reye’s syndrome patients patients 
- 
Controls Stage I Stage II-IV Recovered Fathers Mothers 
6.3 k 0.5 91.4 k 15.5” 23.5 2 2.3* 7.7 t 0.3 9.5 t 0.5 8.5 +- 0.3 
(47) (IO) (37) (44) (1.5) (29) 
.- ~~~ ~~~~~~ ~~~~ ~~ ~~~~ 
Nore. Results are expressed in units/liter as means z SE of the number of samples 
shown in parentheses. *Indicates statistically significant difference (P <O.O.C) as compared 
with controls. 
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serum OCT levels in the convalescent RS patients and in their parents 
(Table 1) suggest that an inherited, inborn metabolic defect was not 
responsible for the increased serum OCT activities in the RS patients. 
It is possible that the interactions of several exogenous factors, such as 
viral infection and drug consumption may have led to the increase in 
serum OCT activities in the RS patients during the early phase of the 
disorder. Studies in an animal model of RS have shown that the combination 
of influenza B viral infection, aspirin treatment, and diet-induced hy- 
perammonemia produce significant increase in serum OCT activity (7). 
Because RS is a rare disease, small number of cases were available 
for this study. In this report, serum OCT analysis of 10 additional RS 
patients supplemented and confirmed our earlier observation in 37 RS 
patients that serum OCT activities are elevated in RS t 1). This study 
also showed, for the first time that the convalescent RS patients and 
their parents have normal levels of serum OCT. Our earlier study showed 
that unlike SGOT activities, elevated serum OCT activities in RS patients 
correlate well with the serum ammonia levels and also with the neurologic 
stages of the disorder t 1). Unlike SGOT, serum OCT is stable for a 
prolonged time and does not change due to hemolysis (1,8). Because 
serum OCT elevation is more specific for liver mitochondrial damage, 
measurement of this enzyme may provide additional staging, diagnostic, 
and prognostic criteria for RS. 
SUMMARY 
Serum levels of omithine carbamyl transferase activities were determined 
in the acutely ill and convalescent Reye’s syndrome patients and in their 
parents. Acutely ill Reye’s syndrome patients had elevated levels of 
serum ornithine carbamyl transferase activities as compared to those in 
controls. The convalescent Reye’s syndrome patients and their parents 
had normal levels of serum ornithine carbamyl transferase activities. 
These results suggest that an inborn metabolic defect was not responsible 
for the increase in serum ornithine carbamyl transferase activities in 
Reye’s syndrome. 
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